Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias

Objective Unclassifiable interstitial lung disease (ILD) is a common problem in clinical practice. These patients pose a distinct challenge with regard to appropriate evaluation and management. We investigated the clinical features and prognosis of unclassifiable ILD and compared its clinical profil...

Full description

Bibliographic Details
Main Authors:	Daniel Traila, Cristian Oancea, Emanuela Tudorache, Ovidiu Fira Mladinescu, Bogdan Timar, Voicu Tudorache
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-01-01
Series:	Journal of International Medical Research
Online Access:	https://doi.org/10.1177/0300060517719767

Similar Items

Cognitive impairment in chronic obstructive pulmonary disease.
by: Alexandru F Crişan, et al.
Published: (2014-01-01)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
by: Marius M Hoeper, et al.
Published: (2015-01-01)

Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation
by: Voicu Tudorache, et al.
Published: (2010-04-01)

Balance impairment in patients with COPD.
by: Alexandru Florian Crişan, et al.
Published: (2015-01-01)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
by: Noriyuki Enomoto, et al.
Published: (2020-06-01)

Comorbidities in unclassifiable interstitial lung disease
by: Thomas Skovhus Prior, et al.
Published: (2022-03-01)

Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
by: Akira Yamagata, et al.
Published: (2021-04-01)

Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype
by: L. P. Ananieva, et al.
Published: (2021-01-01)

Progression of fibrosing interstitial lung disease
by: Alyson W. Wong, et al.
Published: (2020-01-01)

Chronic obstructive pulmonary disease phenotypes and balance impairment
by: Voica AS, et al.
Published: (2016-04-01)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
by: Sergio Harari
Published: (2018-12-01)

Idiopathic interstitial pneumonias
by: Mikhail M. Ilkovich, et al.
Published: (2021-03-01)

Biomarkers of Progressive Fibrosing Interstitial Lung Diseases
by: E. V. Bolotova, et al.
Published: (2023-11-01)

Fibrosing interstitial lung diseases: knowns and unknowns
by: Vincent Cottin, et al.
Published: (2019-02-01)

Nintedanib in chronic fibrosing interstitial lung diseases. A case series
by: Raquel García Sevila, et al.
Published: (2024-04-01)

Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study
by: Milena Adina Man, et al.
Published: (2023-10-01)

Serum and Bronchoalveolar Lavage Fluid Levels of Cytokines in Patients with Lung Cancer and Chronic Lung Disease: A Prospective Comparative Study
by: Patricia Hogea, et al.
Published: (2023-06-01)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
by: Vincent Cottin
Published: (2019-10-01)

Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia
by: Reoto Takei, et al.
Published: (2017-04-01)

Definition, evaluation and therapy of progressive fibrosing interstitial lung disease associated with rheumatic diseases - a consensus paper of the Romanian Society of Rheumatology and Romanian Society of Pneumology
by: Simona Rednic, et al.
Published: (2022-09-01)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
by: Martin Kolb, et al.
Published: (2018-12-01)

The natural history of progressive fibrosing interstitial lung diseases
by: Martin Kolb, et al.
Published: (2019-03-01)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
by: Xianqiu Chen, et al.
Published: (2021-10-01)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
by: Ahmad Abu Qubo, et al.
Published: (2022-01-01)

Role of imaging in progressive-fibrosing interstitial lung diseases
by: Simon L.F. Walsh, et al.
Published: (2018-12-01)

Acute Interstitial Pneumonia and a Role of Diffuse Alveolar Lesion in Different Forms of Idiopathic Fibrosing Alveolitis
by: M. V. Samsonova, et al.
Published: (2006-04-01)

Balance impairment and systemic inflammation in chronic obstructive pulmonary disease
by: Tudorache E, et al.
Published: (2015-09-01)

Idiopathic Lymphocytic Interstitial Pneumonia
Published: (2016-03-01)

Pathology of Idiopathic Interstitial Pneumonias
by: Mikiko Hashisako, et al.
Published: (2015-01-01)

Pathology of Idiopathic Interstitial Pneumonias
by: Mikiko Hashisako, et al.
Published: (2016-02-01)

Idiopathic lymphocytic interstitial pneumonia
by: Chinnu Sasikumar, et al.
Published: (2018-01-01)

Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
by: Ulrike Schmid, et al.
Published: (2021-07-01)

The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis
by: Manolescu D, et al.
Published: (2018-03-01)

Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions
by: Won-Il Choi
Published: (2021-03-01)

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
by: Carlo Albera, et al.
Published: (2021-09-01)

Cluster features in fibrosing interstitial lung disease and associations with prognosis
by: Yuanying Wang, et al.
Published: (2023-11-01)

Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease.
by: Mayuko Watase, et al.
Published: (2023-01-01)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
by: Vincent Cottin, et al.
Published: (2021-03-01)

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
by: Byoung Soo Kwon, et al.
Published: (2021-10-01)

Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases
by: Yunxin Lai, et al.
Published: (2021-11-01)